Related Experiment Video
Updated: Jul 3, 2026
Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
Published on: July 21, 2023
Novel potential mechanisms for diabetic macular edema: leveraging new investigational approaches
Thomas W Gardner1, David A Antonetti
1Department of Ophthalmology, Penn State College of Medicine, HU19, 500 University Drive, Hershey, PA 17033, USA. tgardner@psu.edu
Abstract:
This article evaluates the current knowledge of the molecular mechanisms by which diabetes ocular and systemic inflammation induce breakdown of the blood-retinal barrier resulting in macular edema. We also summarize the relationship between molecular targets and the use of therapeutic inhibitors in preclinical studies and clinical trials. Further studies are needed to understand the regulation of normal blood-retinal barrier physiology and the relationship between events in animal models of diabetic retinopathy and humans with diabetes.
Insights
Diabetes and inflammation break down the blood-retinal barrier, causing macular edema. Understanding these molecular mechanisms may lead to new treatments for diabetic retinopathy.
Area of Science:
- Ophthalmology
- Diabetology
- Molecular Biology
Background:
- Diabetic retinopathy is a leading cause of vision loss.
- Macular edema, a common complication, results from blood-retinal barrier breakdown.
- Inflammation plays a critical role in this process.
Purpose of the Study:
- To review the molecular mechanisms linking diabetes, inflammation, and blood-retinal barrier dysfunction.
- To summarize therapeutic strategies targeting molecular pathways in preclinical and clinical studies.
- To identify knowledge gaps in understanding blood-retinal barrier regulation.
Main Methods:
- Literature review of preclinical studies and clinical trials.
- Analysis of molecular mechanisms involved in diabetic macular edema.
- Evaluation of therapeutic inhibitors and their targets.
Main Results:
- Diabetes and inflammation trigger molecular events that compromise the blood-retinal barrier.
- Several molecular targets and inhibitors have shown promise in preclinical and clinical settings.
- The translation of findings from animal models to human diabetic retinopathy requires further investigation.
Conclusions:
- Molecular mechanisms underlying diabetic macular edema are complex and involve inflammation.
- Targeted therapies show potential but require further validation.
- More research is needed to fully elucidate blood-retinal barrier physiology and its relevance in human disease.
